Yong Huo

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +13

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Paul M. Ridker, Jean MacFadyen, Peter Libby et al. · The Lancet · 2017 · 886 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +8

Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China

Yong Huo, Jianping Li, Xianhui Qin et al. · JAMA · 2015 · 737 citations

Medicine, Pharmacotherapy, Preventive Medicine +12

Exome-wide association study of plasma lipids in >300,000 individuals

Dajiang J. Liu, Gina M. Peloso, Haojie Yu et al. · Nature Genetics · 2017 · 595 citations · Full text

Life Sciences, Bioinformatics, Molecular Genetics +13

The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease

Hyun Kuk Kim, Udaya S. Tantry, Sidney C. Smith et al. · Thrombosis and Haemostasis · 2020 · 335 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16